Logo image of MNST

MONSTER BEVERAGE CORP (MNST) Stock Fundamental Analysis

USA - NASDAQ:MNST - US61174X1090 - Common Stock

66.16 USD
+1.81 (+2.81%)
Last: 9/16/2025, 8:00:01 PM
66.23 USD
+0.07 (+0.11%)
Pre-Market: 9/17/2025, 8:28:43 AM
Fundamental Rating

6

Overall MNST gets a fundamental rating of 6 out of 10. We evaluated MNST against 32 industry peers in the Beverages industry. MNST has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MNST is valied quite expensively at the moment, while it does show a decent growth rate. These ratings could make MNST a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

MNST had positive earnings in the past year.
MNST had a positive operating cash flow in the past year.
Each year in the past 5 years MNST has been profitable.
MNST had a positive operating cash flow in each of the past 5 years.
MNST Yearly Net Income VS EBIT VS OCF VS FCFMNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of MNST (18.02%) is better than 96.88% of its industry peers.
MNST's Return On Equity of 21.88% is amongst the best of the industry. MNST outperforms 81.25% of its industry peers.
With an excellent Return On Invested Capital value of 22.67%, MNST belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MNST is significantly above the industry average of 11.08%.
The last Return On Invested Capital (22.67%) for MNST is above the 3 year average (19.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.02%
ROE 21.88%
ROIC 22.67%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
MNST Yearly ROA, ROE, ROICMNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

MNST has a Profit Margin of 20.54%. This is amongst the best in the industry. MNST outperforms 90.63% of its industry peers.
In the last couple of years the Profit Margin of MNST has declined.
MNST has a better Operating Margin (28.59%) than 87.50% of its industry peers.
In the last couple of years the Operating Margin of MNST has declined.
The Gross Margin of MNST (55.18%) is better than 71.88% of its industry peers.
In the last couple of years the Gross Margin of MNST has declined.
Industry RankSector Rank
OM 28.59%
PM (TTM) 20.54%
GM 55.18%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
MNST Yearly Profit, Operating, Gross MarginsMNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MNST is creating value.
Compared to 1 year ago, MNST has less shares outstanding
Compared to 5 years ago, MNST has less shares outstanding
Compared to 1 year ago, MNST has a worse debt to assets ratio.
MNST Yearly Shares OutstandingMNST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MNST Yearly Total Debt VS Total AssetsMNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 28.68 indicates that MNST is not in any danger for bankruptcy at the moment.
MNST has a Altman-Z score of 28.68. This is amongst the best in the industry. MNST outperforms 100.00% of its industry peers.
There is no outstanding debt for MNST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 28.68
ROIC/WACC2.61
WACC8.69%
MNST Yearly LT Debt VS Equity VS FCFMNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

MNST has a Current Ratio of 3.52. This indicates that MNST is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.52, MNST belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
A Quick Ratio of 3.00 indicates that MNST has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.00, MNST belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.52
Quick Ratio 3
MNST Yearly Current Assets VS Current LiabilitesMNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.64% over the past year.
Measured over the past years, MNST shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.72% on average per year.
Looking at the last year, MNST shows a small growth in Revenue. The Revenue has grown by 3.70% in the last year.
The Revenue has been growing by 12.27% on average over the past years. This is quite good.
EPS 1Y (TTM)8.64%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%24.39%
Revenue 1Y (TTM)3.7%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%11.1%

3.2 Future

Based on estimates for the next years, MNST will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.73% on average per year.
Based on estimates for the next years, MNST will show a small growth in Revenue. The Revenue will grow by 7.85% on average per year.
EPS Next Y20.74%
EPS Next 2Y16.36%
EPS Next 3Y13.66%
EPS Next 5Y13.73%
Revenue Next Year7.8%
Revenue Next 2Y8.1%
Revenue Next 3Y7.62%
Revenue Next 5Y7.85%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MNST Yearly Revenue VS EstimatesMNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
MNST Yearly EPS VS EstimatesMNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 37.59, the valuation of MNST can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of MNST is on the same level as its industry peers.
MNST's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.20.
With a Price/Forward Earnings ratio of 30.35, MNST can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MNST is on the same level as its industry peers.
MNST's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.71.
Industry RankSector Rank
PE 37.59
Fwd PE 30.35
MNST Price Earnings VS Forward Price EarningsMNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MNST indicates a slightly more expensive valuation: MNST is more expensive than 62.50% of the companies listed in the same industry.
MNST's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 34.83
EV/EBITDA 27.33
MNST Per share dataMNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MNST does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of MNST may justify a higher PE ratio.
A more expensive valuation may be justified as MNST's earnings are expected to grow with 13.66% in the coming years.
PEG (NY)1.81
PEG (5Y)N/A
EPS Next 2Y16.36%
EPS Next 3Y13.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONSTER BEVERAGE CORP

NASDAQ:MNST (9/16/2025, 8:00:01 PM)

Premarket: 66.23 +0.07 (+0.11%)

66.16

+1.81 (+2.81%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners68.22%
Inst Owner Change1.06%
Ins Owners0.49%
Ins Owner Change-0.45%
Market Cap64.60B
Analysts75
Price Target67.75 (2.4%)
Short Float %2.82%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.94%
Min EPS beat(2)-0.21%
Max EPS beat(2)4.08%
EPS beat(4)1
Avg EPS beat(4)-2.85%
Min EPS beat(4)-8.27%
Max EPS beat(4)4.08%
EPS beat(8)2
Avg EPS beat(8)-3.63%
EPS beat(12)3
Avg EPS beat(12)-2.74%
EPS beat(16)3
Avg EPS beat(16)-5.18%
Revenue beat(2)0
Avg Revenue beat(2)-4.34%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)-0.44%
Revenue beat(4)0
Avg Revenue beat(4)-3.28%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)-0.44%
Revenue beat(8)0
Avg Revenue beat(8)-3.56%
Revenue beat(12)0
Avg Revenue beat(12)-3.65%
Revenue beat(16)3
Avg Revenue beat(16)-2.15%
PT rev (1m)5.56%
PT rev (3m)8.45%
EPS NQ rev (1m)0.16%
EPS NQ rev (3m)5.36%
EPS NY rev (1m)2.93%
EPS NY rev (3m)2.18%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)3.91%
Revenue NY rev (1m)1.48%
Revenue NY rev (3m)1.54%
Valuation
Industry RankSector Rank
PE 37.59
Fwd PE 30.35
P/S 8.43
P/FCF 34.83
P/OCF 31.46
P/B 8.98
P/tB 14.55
EV/EBITDA 27.33
EPS(TTM)1.76
EY2.66%
EPS(NY)2.18
Fwd EY3.29%
FCF(TTM)1.9
FCFY2.87%
OCF(TTM)2.1
OCFY3.18%
SpS7.84
BVpS7.36
TBVpS4.55
PEG (NY)1.81
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.02%
ROE 21.88%
ROCE 29.31%
ROIC 22.67%
ROICexc 31.37%
ROICexgc 63.95%
OM 28.59%
PM (TTM) 20.54%
GM 55.18%
FCFM 24.22%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
ROICexc(3y)29.02%
ROICexc(5y)32.32%
ROICexgc(3y)64.44%
ROICexgc(5y)84.58%
ROCE(3y)25.4%
ROCE(5y)26.54%
ROICexcg growth 3Y-12.83%
ROICexcg growth 5Y-13.62%
ROICexc growth 3Y-5.49%
ROICexc growth 5Y-2.02%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 213.85%
Cap/Sales 2.59%
Interest Coverage 75.62
Cash Conversion 89.98%
Profit Quality 117.9%
Current Ratio 3.52
Quick Ratio 3
Altman-Z 28.68
F-Score7
WACC8.69%
ROIC/WACC2.61
Cap/Depr(3y)319.34%
Cap/Depr(5y)225.06%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.29%
Profit Quality(3y)86.9%
Profit Quality(5y)86.95%
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%24.39%
EPS Next Y20.74%
EPS Next 2Y16.36%
EPS Next 3Y13.66%
EPS Next 5Y13.73%
Revenue 1Y (TTM)3.7%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%11.1%
Revenue Next Year7.8%
Revenue Next 2Y8.1%
Revenue Next 3Y7.62%
Revenue Next 5Y7.85%
EBIT growth 1Y8.74%
EBIT growth 3Y4.5%
EBIT growth 5Y7.79%
EBIT Next Year15.32%
EBIT Next 3Y10.91%
EBIT Next 5Y11.93%
FCF growth 1Y37.56%
FCF growth 3Y14.4%
FCF growth 5Y10.46%
OCF growth 1Y35.1%
OCF growth 3Y18.61%
OCF growth 5Y11.61%